Last reviewed · How we verify
NCT06882200: OBEDIVE
A Combined Mindfulness-diving Protocol on Emotional Eating in Obese Patients: A Prospective Randomized Study
NA trial testing A combined mindfulness and therapeutic scuba-diving protocol in Obesity and Overweight in 63 participants. Completed in 30 April 2023.
1 November 2022
Quick facts
| Lead sponsor | BATHYSMED |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 63 |
| Start date | 1 July 2022 |
| Primary completion | 1 November 2022 |
| Estimated completion | 30 April 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- A combined mindfulness and therapeutic scuba-diving protocol
- Control group regular follow up in primary care
Conditions studied
- Obesity and Overweight — all drugs for Obesity and Overweight →
Sponsor
BATHYSMED
Who can join
Under 60, any sex, with Obesity and Overweight. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to learn if a combined minfulness-diving program has an impact on emotional eating in adults with obesity. The main questions it aims to answer are: Does the BathysMed protocol have an impact on emotional eating after the 2 months diving protocol? Researchers will compare the diving program to a control group of adult patients with obesity. Participants will be asked to participate in the combined mindfulness-diving protocol for 2 months, and complete the questionnaires at baseline, 2, 5, and 8 months follow up.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Efficacy of a combined diving and mindfulness program on emotional eating in adults with obesity: Randomised controlled trial with standard care.
Griffiths K, Markarian T, Meurice V, Muzellec M, et al · · 2026 · PMID 41894522 · DOI 10.1371/journal.pone.0345784
Verify or expand the search:
- PubMed search for NCT06882200
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity and Overweight
Currently open trials in the same condition.
- NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
- NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
- NCT07032545 — Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors · NA · recruiting
- NCT06768827 — New Mechanisms of Obesity · NA · recruiting
- NCT06935838 — Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06882200 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by BATHYSMED
- Last refreshed: 18 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06882200.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing